A Day Up For Nuvation Bio Inc. Class A
Wed, Mar 27, 2024 at 07:18 PM
Nuvation Bio Inc. Class A (NUVB:NYSE) shot up at $3.97, representing a gain of 37.8%. On Wed, Mar 27, 2024, NUVB:NYSE hit a New 2-Week High of $3.97. The stock got featured on our News Catalysts scanner on Mon, Mar 25, 2024 at 09:02 AM in the 'ACQUISITION' category. From Wed, Mar 13, 2024, the stock recorded 50.00% Up Days and 63.64% Green Days
About Nuvation Bio Inc. Class A (NUVB:NYSE)
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology.
Top 10 Gainers:
- iBio, Inc. (IBIO:NYSEMKT), 192.17%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 101.92%
- Cazoo Group Ltd Class A (CZOO:NYSE), 100.96%
- Destiny Tech100 Inc. (DXYZ:NYSE), 95.56%
- MariaDB plc (MRDB:NYSE), 94.25%
- two Class A (TWOA:NYSE), 71.47%
- Ontrak Inc. (OTRK:NASDAQ), 38.69%
- NuScale Power Corporation Class A (SMR:NYSE), 38.22%
- Nuvation Bio Inc. Class A (NUVB:NYSE), 37.85%
- Stoke Therapeutics, Inc. (STOK:NASDAQ), 37.71%